Dmitry Ochinnikov, Ph.D.
Dmitry Ovchinnikov, Ph.D., has served as the General Director of Selecta’s Russian operations since August 2013, and served as General Deputy Director from May 2012 to August 2013. Prior to joining Selecta, Dr. Ovchinnikov was a Medical Director for ZAO Sandoz (Russia), a Novartis company, from December 2010 to May 2012, and was responsible for medical support and compliance, clinical trials and pharmacovigilance.
Dr. Ovchinnikov was also a member of the Russia Executive Committee at Sandoz and took part in the elaboration of development strategy for the Russian branch. From November 2006 to December 2010, Dr. Ovchinnikov worked at Janssen-Cilag, a Johnson & Johnson company, as a Medical Manager for Russia and the Commonwealth of Independent States, and from December 2004 to November 2006, he served as a Clinical Research Associate for PAREXEL RUS LLC, a life sciences consulting firm and a division of PAREXEL International. Dr. Ovchinnikov received his M.S. and Ph.D. in Biochemistry/Oncology/Virology from Lomonosov Moscow State University in Moscow, Russia.